Related references
Note: Only part of the references are listed.Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation
Thomas Thiele et al.
TRANSFUSION (2012)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
A comparison of methods of pathogen inactivation of FFP
G. Rock
VOX SANGUINIS (2011)
Updates on pathogen inactivation of plasma using Theraflex methylene blue system
Jerard Seghatchian et al.
TRANSFUSION AND APHERESIS SCIENCE (2008)
Fc function of a new intravenous immunoglobulin product: IGIV 10% triple virally inactivated solution
B. M. Reipert et al.
VOX SANGUINIS (2006)
Share Paper
